80832-44-6 Usage
Uses
Used in Pharmaceutical and Medical Industries:
Pyracrenic acid is used as a potential candidate for the development of new drugs and treatments for various diseases due to its diverse biological activities, including anti-inflammatory, anti-tumor, and anti-microbial properties.
Used in Cancer Treatment:
Pyracrenic acid is used as an anti-tumor agent for inhibiting the growth of various cancer cells, making it a promising candidate for cancer treatment.
Used in Anti-Inflammatory Applications:
Pyracrenic acid is used as an anti-inflammatory agent for reducing inflammation, which can be beneficial in treating various inflammatory conditions.
Used in Anti-Microbial Applications:
Pyracrenic acid is used as an anti-microbial agent for displaying antibacterial and antifungal activities, making it a potential candidate for treating microbial infections.
Check Digit Verification of cas no
The CAS Registry Mumber 80832-44-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,0,8,3 and 2 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 80832-44:
(7*8)+(6*0)+(5*8)+(4*3)+(3*2)+(2*4)+(1*4)=126
126 % 10 = 6
So 80832-44-6 is a valid CAS Registry Number.
InChI:InChI=1/C39H54O6/c1-23(2)25-14-19-39(34(43)44)21-20-37(6)26(33(25)39)10-12-30-36(5)17-16-31(35(3,4)29(36)15-18-38(30,37)7)45-32(42)13-9-24-8-11-27(40)28(41)22-24/h8-9,11,13,22,25-26,29-31,33,40-41H,1,10,12,14-21H2,2-7H3,(H,43,44)/b13-9+/t25-,26+,29-,30+,31-,33+,36-,37+,38+,39-/m0/s1
80832-44-6Relevant academic research and scientific papers
Antimycobacterial activity of cinnamate-based esters of the triterpenes betulinic, oleanolic and ursolic acids
Tanachatchairatana, Tanud,Bremner, John Barnard,Chokchaisiri, Ratchanaporn,Suksamrarn, Apichart
, p. 194 - 198 (2008/09/18)
Betulinic acid, oleanolic acid and ursolic acid have been modified at the C-3 position to cinnamate-based esters and in vitro antimycobacterial activity against Mycobacterium tuberculosis H37Ra has been determined. The results indicated that mo
Synthetic pentacyclic triterpenoids and derivatives of betulinic acid and betulin
-
Page/Page column 50-51, (2010/11/28)
The present invention comprises small molecule inhibitors of cell proliferative conditions, in particular cancer and conditions associated with cancer. For example, associated malignancies include ovarian cancer, cervical cancer, breast cancer, colorectal cancer, and glioblastomas, among others. Accordingly, the compounds of the present invention are useful for treating, preventing, and/or inhibiting these diseases. Thus, the present invention also comprising pharmaceutical formulations comprising the compounds and methods of using the compounds and formulations to inhibit cancer and treat, prevent, or inhibit the foregoing diseases.
